132 related articles for article (PubMed ID: 34049793)
1. Long-term trend in serum (1,3)-β-D-glucan level in a man with chronic disseminated candidiasis treated with corticosteroids.
Shirahige T; Tashiro M; Taguchi M; Miyazaki Y; Shibuya K; Izumikawa K
J Infect Chemother; 2021 Aug; 27(8):1258-1260. PubMed ID: 34049793
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of corticosteroid therapy during chronic disseminated candidiasis: case reports and literature review.
Chaussade H; Bastides F; Lissandre S; Blouin P; Bailly E; Chandenier J; Gyan E; Bernard L
J Antimicrob Chemother; 2012 Jun; 67(6):1493-5. PubMed ID: 22374323
[TBL] [Abstract][Full Text] [Related]
4. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
[TBL] [Abstract][Full Text] [Related]
5. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
[TBL] [Abstract][Full Text] [Related]
6. Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature.
Shkalim-Zemer V; Levi I; Fischer S; Tamary H; Yakobovich J; Avrahami G; Gilad G; Elitzur S; Yaniv I; Elhasid R; Manistersky M; Shalit I
Pediatr Infect Dis J; 2018 Jul; 37(7):686-690. PubMed ID: 29140934
[TBL] [Abstract][Full Text] [Related]
7. Chronic Disseminated Candidiasis in Children and the Role of Corticosteroids Therapy.
Al Yazidi LS; Elsidig N; Wali Y; Nazir H
Pediatr Infect Dis J; 2023 May; 42(5):e146-e151. PubMed ID: 36795580
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
Guo J; Wu Y; Lai W; Lu W; Mu X
BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant corticosteroid therapy for chronic disseminated candidiasis.
Legrand F; Lecuit M; Dupont B; Bellaton E; Huerre M; Rohrlich PS; Lortholary O
Clin Infect Dis; 2008 Mar; 46(5):696-702. PubMed ID: 18230039
[TBL] [Abstract][Full Text] [Related]
10. Letter on "(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial".
Kritikos A; Lamoth F
Crit Care; 2021 Feb; 25(1):55. PubMed ID: 33563306
[No Abstract] [Full Text] [Related]
11. (1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Bloos F; Held J; Kluge S; Simon P; Kogelmann K; de Heer G; Kuhn SO; Jarczak D; Motsch J; Hempel G; Weiler N; Weyland A; Drüner M; Gründling M; Meybohm P; Richter D; Jaschinski U; Moerer O; Günther U; Schädler D; Weiss R; Putensen C; Castellanos I; Kurzai O; Schlattmann P; Cornely OA; Bauer M; Thomas-Rüddel D;
Intensive Care Med; 2022 Jul; 48(7):865-875. PubMed ID: 35708758
[TBL] [Abstract][Full Text] [Related]
12. The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery.
White PL; Posso R; Parr C; Price JS; Finkelman M; Barnes RA
Clin Infect Dis; 2021 Oct; 73(7):e1415-e1422. PubMed ID: 32914187
[TBL] [Abstract][Full Text] [Related]
13. Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysis.
Pang YK; Ip M; You JHS
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):187-194. PubMed ID: 27686799
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of Chronic Disseminated Candidiasis Complicated by Immune Reconstitution Inflammatory Syndrome in a Child With Acute Lymphocytic Leukemia.
Mosleh S; Rabaia D; Zidan T
Cureus; 2023 Aug; 15(8):e44103. PubMed ID: 37750159
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis.
Kritikos A; Poissy J; Croxatto A; Bochud PY; Pagani JL; Lamoth F
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238435
[TBL] [Abstract][Full Text] [Related]
16. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
[TBL] [Abstract][Full Text] [Related]
17. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
[TBL] [Abstract][Full Text] [Related]
18. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
19. β-(1→3)-D-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study.
Erb T; Mihai S; Strauß R; Herbst L; Castellanos I; Diesch K; Cipa F; Bihlmaier K; Lang A-K; Ganslmayer M; Willam C; Bremer F; Fürst J; Beyer C; Bogdan C; Rath A; Held J
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0072523. PubMed ID: 37823695
[No Abstract] [Full Text] [Related]
20. (1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial.
De Pascale G; Posteraro B; D'Arrigo S; Spinazzola G; Gaspari R; Bello G; Montini LM; Cutuli SL; Grieco DL; Di Gravio V; De Angelis G; Torelli R; De Carolis E; Tumbarello M; Sanguinetti M; Antonelli M
Crit Care; 2020 Sep; 24(1):550. PubMed ID: 32891170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
